These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 37789589)

  • 1. Complete dissection of right paratracheal lymph nodes (stations 2R and 4R) is critical to improve the prognosis of lung cancer patients: A retrospective cohort study.
    Zhao K; Mei J; Hu B; Guo C; Wei S; Yang X; Yang Z; Zhang J; Ku Y; Zheng Y; Wu D; Li S; Mao Y; Ding Y; Liu L
    Thorac Cancer; 2023 Nov; 14(33):3309-3316. PubMed ID: 37789589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of 4R lymph node dissection in patients with right primary non-small cell lung cancer.
    Zhou D; Yue D; Zhang Z; Tian P; Feng Y; Liu Z; Zhang B; Wang M; Zhao X; Wang C
    World J Surg Oncol; 2022 Jul; 20(1):222. PubMed ID: 35778770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative paratracheal lymph node dissection in left-sided hilar lung cancer patients: comparing the number of lymph nodes dissected to the number of lymph nodes dissected in right-sided mediastinal dissections.
    Toker A; Tanju S; Ziyade S; Kaya S; Erus S; Ozkan B; Yilmazbayhan D
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):974-80. PubMed ID: 21276734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of removal for mediastinal nodal stations for patients with clinical stage I non-small cell lung cancer: effect on outcome.
    Jeon HW; Moon MH; Kim KS; Kim YD; Wang YP; Park HJ; Park JK
    Thorac Cardiovasc Surg; 2014 Oct; 62(7):599-604. PubMed ID: 24420680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Video-assisted vs open mediastinal lymphadenectomy for Stage I non-small-cell lung cancer: results of a prospective randomized trial.
    Palade E; Passlick B; Osei-Agyemang T; Günter J; Wiesemann S
    Eur J Cardiothorac Surg; 2013 Aug; 44(2):244-9; discussion 249. PubMed ID: 23295451
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.
    Darling GE; Allen MS; Decker PA; Ballman K; Malthaner RA; Inculet RI; Jones DR; McKenna RJ; Landreneau RJ; Rusch VW; Putnam JB
    J Thorac Cardiovasc Surg; 2011 Mar; 141(3):662-70. PubMed ID: 21335122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Number of mediastinal lymph nodes in non-small cell lung cancer: a Gaussian curve, not a prognostic factor.
    Riquet M; Legras A; Mordant P; Rivera C; Arame A; Gibault L; Foucault C; Dujon A; Le Pimpec Barthes F
    Ann Thorac Surg; 2014 Jul; 98(1):224-31. PubMed ID: 24820386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lobe-specific lymph node dissection in stage IA non-small-cell lung cancer: a retrospective cohort study.
    Abughararah TZ; Jeong YH; Alabbood F; Chong Y; Yun JK; Lee GD; Choi S; Kim HR; Kim YH; Kim DK; Park SI
    Eur J Cardiothorac Surg; 2021 Apr; 59(4):783-790. PubMed ID: 33150427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival Benefit of Left Lower Paratracheal (4L) Lymph Node Dissection for Patients with Left-Sided Non-small Cell Lung Cancer: Once Neglected But of Great Importance.
    Zhao K; Wei S; Mei J; Guo C; Hai Y; Chen N; Liu L
    Ann Surg Oncol; 2019 Jul; 26(7):2044-2052. PubMed ID: 31011902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathological characteristics and lymph node metastasis pathway of non-small-cell lung cancer located in the left lingular division.
    Shien K; Toyooka S; Soh J; Okami J; Higashiyama M; Kadota Y; Maeda H; Hayama M; Chida M; Funaki S; Okumura M; Miyoshi S
    Interact Cardiovasc Thorac Surg; 2015 Jun; 20(6):791-6. PubMed ID: 25805399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic role of station 3A mediastinal nodes for non-small-cell lung cancers.
    Zheng H; Gao W; Fei K; Xie HK; Jiang GN; Ding JA; Li C; Chen C; Zhang L
    Interact Cardiovasc Thorac Surg; 2013 Sep; 17(3):447-54. PubMed ID: 23788199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy?
    Turna A; Solak O; Kilicgun A; Metin M; Sayar A; Gürses A
    Thorac Cardiovasc Surg; 2007 Mar; 55(2):112-9. PubMed ID: 17377865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Factors influencing survival and recurrence and potential significance of postoperative radiotherapy and adjuvant chemotherapy for stage ⅢA-N2 non-small cell lung cancer].
    Han W; Song YZ; He M; Li J; Zhang R; Qiao XY
    Zhonghua Zhong Liu Za Zhi; 2016 Nov; 38(11):861-867. PubMed ID: 27998447
    [No Abstract]   [Full Text] [Related]  

  • 14. Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer.
    Shapiro M; Kadakia S; Lim J; Breglio A; Wisnivesky JP; Kaufman A; Lee DS; Flores RM
    Chest; 2013 Nov; 144(5):1615-1621. PubMed ID: 23828253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dissection of 4L lymph node for left-sided non-small cell lung cancer: a meta-analysis.
    Deng HY; Li D; Qiu XM; Zhu DX; Tang X; Zhou Q
    ANZ J Surg; 2021 Nov; 91(11):E696-E702. PubMed ID: 34405519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of standard number, size and weight of mediastinal lymph nodes in postmortem examinations: reflection on lung cancer surgery.
    Ziyade S; Pinarbasili NB; Ziyade N; Akdemir OC; Sahin F; Soysal Ö; Toker A
    J Cardiothorac Surg; 2013 Apr; 8():94. PubMed ID: 23591054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non-Small Cell Lung Cancer After Resection With Curative Intent.
    Smeltzer MP; Faris NR; Ray MA; Osarogiagbon RU
    JAMA Oncol; 2018 Jan; 4(1):80-87. PubMed ID: 28973110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of mediastinal lymph nodes sampling in patients with clinical stage I non-small cell lung cancer.
    Takizawa H; Kondo K; Matsuoka H; Uyama K; Toba H; Kenzaki K; Sakiyama S; Tangoku A; Miura K; Yoshizawa K; Morita J
    J Med Invest; 2008 Feb; 55(1-2):37-43. PubMed ID: 18319543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Significance of Station 3A Lymph Node Dissection in Patients with Right-Side Non-Small-Cell Lung Cancer: A Retrospective Propensity-Matched Analysis.
    Liu C; Wei S; Guo C; Mei J; Pu Q; Liu L
    Ann Surg Oncol; 2021 Jan; 28(1):194-202. PubMed ID: 32638165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of station 4L lymph node dissection on short-term and long-term outcomes in non-small cell lung cancer.
    Wo Y; Li H; Zhang Y; Peng Y; Wu Z; Liu P; Shang Y; Hu H; Zhang Y; Xiang J; Sun Y
    Lung Cancer; 2022 Aug; 170():141-147. PubMed ID: 35780588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.